Merger Guidelines: The 11 Antitrust Rules and How They Apply

The federal merger guidelines are the analytical framework the Federal Trade Commission and Department of Justice use to decide whether a proposed acquisition or combination threatens competition. The current version, issued jointly in December 2023, sets out eleven principles covering horizontal deals between direct rivals, vertical deals up and down a supply chain, digital platforms, labor markets, and patterns of serial acquisition.¹ They are not statutes, but courts treat them as persuasive authority, and the agencies use them to decide which deals to investigate, challenge, or clear.

What Legal Force the Guidelines Carry

The guidelines interpret existing antitrust law rather than create new law. Section 7 of the Clayton Act prohibits any acquisition whose effect “may be substantially to lessen competition, or to tend to create a monopoly.”² Sections 1 and 2 of the Sherman Act and Section 5 of the FTC Act round out the enforcement toolkit, covering anticompetitive agreements, monopolization, and unfair methods of competition.³

The guidelines themselves are a public statement of how the agencies read those statutes. Companies planning a deal can use the document to predict how their transaction will be analyzed; federal courts routinely cite it when ruling on merger challenges. That means the guidelines are not binding on a judge, but ignoring them is risky for anyone trying to close a large transaction without a fight.

The Eleven Guidelines

The 2023 framework organizes merger analysis around eleven distinct theories of harm. A single deal can be challenged under more than one at the same time.¹

Guideline 1: Mergers that significantly increase concentration in a highly concentrated market raise a presumption of illegality.
Guideline 2: Mergers that eliminate substantial competition between the merging firms.
Guideline 3: Mergers that increase the risk of coordination among remaining competitors.
Guideline 4: Mergers that eliminate a potential entrant in a concentrated market.
Guideline 5: Mergers that create a firm able to limit rivals’ access to products or services they need to compete.
Guideline 6: Mergers that entrench or extend a dominant position.
Guideline 7: When an industry is trending toward consolidation, regulators consider whether each new deal adds to the risk.
Guideline 8: When a merger is part of a series of acquisitions, regulators examine the whole pattern.
Guideline 9: Mergers involving multi-sided platforms, including competition between platforms, on a platform, or to displace a platform.
Guideline 10: Mergers between competing buyers that may harm workers, suppliers, or other providers.
Guideline 11: Acquisitions involving partial ownership or minority interests.

How Regulators Define the Market First

Before any of these theories can be applied, regulators have to define the market where competition happens. The definition has two parts: which products compete with one another, and the geographic area where they compete.

The primary tool is the hypothetical monopolist test. Regulators ask whether a hypothetical single seller of a candidate set of products in a candidate area could profitably impose a small but significant and non-transitory price increase. If enough customers would switch to something outside that set to make the increase unprofitable, the market has been drawn too narrowly and needs to be widened. If the hypothetical monopolist could sustain the increase, the candidate set is a relevant market.¹

Every concentration figure and competitive assessment that follows depends on this step. A market drawn too broadly makes a dominant merger look harmless; one drawn too narrowly can make an insignificant deal look monopolistic.

The Concentration Math: HHI Thresholds

Regulators measure concentration with the Herfindahl-Hirschman Index. Take each firm’s market share as a percentage, square it, and add the results. Five equal firms at 20 percent each produces an HHI of 2,000. A monopolist at 100 percent produces an HHI of 10,000.⁴

The 2023 guidelines set the structural presumption of illegality at an HHI above 1,800 combined with a merger-caused increase of more than 100 points. When a deal crosses that line, regulators presume it will substantially lessen competition, and the burden shifts to the merging companies to rebut. A separate presumption applies when the merged firm would hold more than 30 percent of the market and the HHI increases by more than 100 points.¹

Losing a Direct Rival: Unilateral Effects

Guideline 2 addresses the most intuitive horizontal problem. When two companies that compete for the same customers combine, the merged firm may be able to raise prices because it no longer risks losing sales to its former rival. Because the merged firm can do this on its own, without any cooperation from remaining competitors, the agencies call the concern “unilateral effects.”¹

The strength of this concern depends on how closely the two firms competed before the deal. Regulators look at internal documents showing how each firm tracked the other’s pricing, at customer win-loss records, and at switching patterns. If a meaningful share of customers would have chosen one of the merging firms as their second choice, the deal removes exactly the competitive pressure that had been keeping prices down. Two firms at 15 percent share each may look modest on paper, but if they were each other’s primary alternative, combining them removes a constraint no other competitor can replace.

Coordinated Effects

Guideline 3 covers a different horizontal risk: the merger makes tacit coordination easier among the firms that remain. In a market with few players, each firm can watch its rivals and adjust accordingly, refraining from aggressive price cuts because it expects rivals to match. This kind of parallel behavior is more likely as concentration rises.¹

The agencies treat coordination as especially dangerous because tacit parallelism often falls outside Section 1 of the Sherman Act, which requires an actual agreement. Merger review is therefore the primary preventive tool. A market that is already highly concentrated or has a history of attempted price-fixing is treated as inherently vulnerable, and the presumption of increased coordination risk applies unless the parties rebut it. Regulators also watch for the elimination of a maverick firm, one whose aggressive or unconventional behavior had been disrupting coordination among more cautious rivals.

Buying Out Future Competition

Guideline 4 protects competition that has not yet materialized. When a dominant company acquires a firm positioned to enter its market, the deal removes a future threat that would have benefited consumers.

The agencies analyze this under two theories. Perceived potential competition applies when an incumbent has been holding prices lower than it otherwise would because it knows a specific company on the sidelines could enter; acquiring that company removes the disciplinary effect of the threat. Actual potential competition applies when the acquired firm was genuinely likely to enter the market on its own. Under this theory the government must show entry was reasonably probable and that the acquired firm was one of only a few realistic potential entrants.¹

This concern carries particular weight in technology and pharmaceutical markets, where large incumbents sometimes acquire startups with disruptive products before those products reach full commercialization. Regulators scrutinize internal business plans, capital investment, and development timelines to test whether the target was really on a path to independent entry.

Vertical Mergers and Foreclosure

Guideline 5 covers deals where a company acquires a supplier, distributor, or other business its rivals depend on. The core risk is foreclosure: after the deal closes, the merged firm could degrade, delay, or deny competitors’ access to a critical input or route to market.¹

Foreclosure does not require refusing to deal. The merged firm might raise the input’s price, reduce its quality, limit interoperability, or slow access to updates. Any of these raises rivals’ costs. The agencies assess both the ability and the incentive to foreclose. Ability turns on whether substitute inputs exist and how important the merged firm’s product is to competitors. Incentive turns on whether the profits gained from weakening downstream rivals outweigh revenues lost by restricting upstream sales. A vertical deal can also give the combined firm access to competitors’ confidential business information passing through the acquired unit.

Labor Markets and Monopsony Power

Guideline 10 reflects a substantive expansion of modern enforcement: regulators now evaluate a merger’s impact on workers, not only consumers. When two major employers in the same industry or region combine, the merged firm may gain monopsony power, the buyer-side equivalent of a monopoly. With fewer competing employers, workers lose leverage over wages, benefits, and working conditions.

Labor is treated as a distinct market. A deal can be challenged on labor grounds even if it lowers consumer prices, provided it substantially reduces competition for workers. The agencies look at whether employees have realistic alternative employers for their skill sets and whether the merged firm would control a large enough share of local job opportunities to suppress compensation.¹

Non-compete clauses inside merger agreements draw scrutiny as well. The FTC has flagged overbroad non-competes reaching beyond the geographic area or business line actually being acquired, and has required parties to narrow their duration and scope as a condition of closing.⁵

Platforms, Dominance, and Entrenchment

Guideline 9 addresses multi-sided platforms that connect different groups of users, such as marketplaces, app stores, and advertising networks. These businesses benefit from network effects, where each additional user makes the platform more valuable to everyone else. That dynamic creates durable entry barriers: once a platform reaches critical mass, a new competitor struggles to attract enough users on all sides to be viable.

The guideline recognizes three types of platform competition: between rival platforms, among businesses competing on a single platform, and from potential disruptors trying to displace an established platform entirely. A merger raises concerns when it lets a dominant platform owner favor its own products over those of businesses that depend on the same platform for distribution.¹ Guideline 6 reinforces this by flagging any merger that entrenches or extends an already dominant position, even where the acquired company does not directly compete in the same product market.

Serial Acquisitions

Guidelines 7 and 8 address roll-up patterns: companies that grow through many small acquisitions, each one individually below the radar but collectively transforming a market. The agencies now examine whether a merger is part of a broader series of transactions and evaluate the cumulative effect of the pattern, not just the deal in front of them.¹

Where an industry is trending toward consolidation, each additional deal draws heightened scrutiny on the theory that each step makes the remaining competition more fragile. The principle matters most in healthcare, technology, and private equity roll-ups, where a single firm may acquire hundreds of small competitors over several years. A deal that looks harmless in isolation can be the transaction that tips a market past the point of effective competition.

Defenses: Efficiencies and Failing Firm

Companies whose deals trigger a presumption of illegality still have paths to clear the review, but the bar is high. Under the efficiencies defense, merging parties must show competitive benefits that meet four requirements:¹

Merger-specific. The benefits could not be achieved through internal growth, contracts, or a less anticompetitive alternative.
Verifiable. Claimed savings must rest on reliable methodology, not the parties’ own projections.
Passed through to consumers. Benefits that only help the merged firm’s bottom line do not count; the efficiencies must prevent the competitive harm the deal would otherwise cause, and they must do so within a short time.
Not anticompetitive in themselves. Cost savings that come from worsening terms for suppliers or other trading partners are excluded.

In practice the efficiencies defense rarely succeeds alone. Efficiencies that would not prevent a monopoly cannot justify a merger that tends to create one.

The failing firm defense is narrower still. Three requirements all have to be satisfied: the target faces the grave probability of imminent business failure and cannot meet its financial obligations in the near future; it cannot successfully reorganize under Chapter 11; and it has made good-faith efforts to find an alternative buyer whose acquisition would pose a lesser threat to competition, and those efforts failed.¹ Declining sales or losses alone are not enough.

Remedies When Concerns Are Identified

Where a deal raises concerns but the harm can be surgically removed, the agencies negotiate remedies rather than block the transaction outright. Federal enforcers strongly prefer structural remedies, meaning divestitures of business units or assets, over behavioral remedies that impose ongoing conduct rules on the merged firm.

A divestiture package is expected to consist of a self-sustaining, standalone business. Where it falls short, the parties must show it includes everything a buyer would need to compete effectively. The buyer itself must be financially stable, experienced in the industry, and capable of replacing the competitive intensity that would otherwise be lost.⁵

The agencies often require the buyer to be identified before the consent order is finalized, particularly when the divested assets are vulnerable to deterioration or consist primarily of intellectual property. Pending divestiture, the merging parties must hold the assets separate and maintain their competitive viability, and the FTC may appoint an independent monitor to oversee compliance.⁵ Behavioral remedies such as firewalls or pricing commitments are generally disfavored because they are difficult to enforce over time, and are accepted mainly where the concern is coordination risk and a structural fix is not feasible.

How the Guidelines Get Applied to Real Deals

The guidelines only matter if the agencies see the deal in the first place. The Hart-Scott-Rodino Act requires companies planning larger transactions to notify both the FTC and DOJ before closing, pay a filing fee, and observe a statutory waiting period.⁶ For 2026, a transaction triggers mandatory notification when the value of voting securities and assets being acquired exceeds $133.9 million, with a size-of-person test bringing in some smaller deals; the thresholds are adjusted annually based on changes in gross national product.⁷

Once a complete filing is received, a 30-day waiting period begins, or 15 days for a cash tender offer.⁶ If the reviewing agency identifies competitive concerns during that window, it issues a Second Request, which extends the waiting period and forces both parties to produce extensive business documents and data before they can close.⁸ Second Request compliance often costs millions in legal and document-production fees and can stretch for months. Closing before the waiting period expires, known as gun-jumping, can bring substantial civil penalties.

Below the HSR thresholds, no premerger filing is required, but the agencies retain authority to investigate and challenge deals of any size after the fact under the same eleven guidelines. Size determines only whether notification is mandatory, not whether the substantive standards apply.

1
Federal Trade Commission. Merger Guidelines
2
Office of the Law Revision Counsel. 15 US Code 18 – Acquisition by One Corporation of Stock of Another
3
United States Department of Justice. 2023 Merger Guidelines
4
U.S. Department of Justice. Herfindahl-Hirschman Index
5
Federal Trade Commission. Negotiating Merger Remedies
6
Office of the Law Revision Counsel. 15 US Code 18a – Premerger Notification and Waiting Period
7
Federal Trade Commission. New HSR Thresholds and Filing Fees for 2026
8
Federal Trade Commission. Premerger Notification and the Merger Review Process